99% Savings - Buy Just @1 Rs X
Kinaplat 100 mg Infusion is a prescription drug, available for use as Infusion. It is typically used for the treatment of Colorectal Cancer. Kinaplat 100 mg Infusion also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Kinaplat 100 mg Infusion. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Kinaplat 100 mg Infusion as well, which are listed below. These side effects of Kinaplat 100 mg Infusion are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Kinaplat 100 mg Infusion has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Kinaplat 100 mg Infusion's effects on the liver, heart and kidney are discussed below in the Kinaplat 100 mg Infusion related warnings section.
Kinaplat 100 mg Infusion is contraindicated in people with pre-existing medical conditions like Arrhythmia as it can result in adverse effects. The section on Kinaplat 100 mg Infusion contraindications lists all such conditions.
Additionally, Kinaplat 100 mg Infusion may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Kinaplat 100 mg Infusion is not safe while driving, and is is not addictive in nature.
Kinaplat 100 mg Infusion is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Kinaplat 100 mg Infusion safe for pregnant women?
Kinaplat can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Kinaplat 100 mg Infusion safe during breastfeeding?
Kinaplat may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Kinaplat 100 mg Infusion on the Kidneys?
Kinaplat has very mild side effects on the kidneys.
What is the effect of Kinaplat 100 mg Infusion on the Liver?
You may experience side effects on your liver after taking Kinaplat. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Kinaplat 100 mg Infusion on the Heart?
You may experience side effects on your heart after taking Kinaplat. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Kinaplat 100 mg Infusion unless your doctor advises you to do so -
Is this Kinaplat 100 mg Infusion habit forming or addictive?
Forming a habit of Kinaplat 100 mg Infusion has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Kinaplat 100 mg Infusion as you may feel sleepy.
Is it safe?
Kinaplat 100 mg Infusion should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Kinaplat 100 mg Infusion for mental disorders.
Interaction between Food and Kinaplat 100 mg Infusion
Taking Kinaplat 100 mg Infusion with food is safe.
Interaction between Alcohol and Kinaplat 100 mg Infusion
Consumption of alcohol and Kinaplat 100 mg Infusion together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 954-956
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Eloxatin (oxaliplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Oxaliplan™ (oxaliplatin)